WHITEHAWK THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $273.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2022-05-12
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $273.00K.
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $273.00K.
- 2021-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $273.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2022-03-31 | $273.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $273.00K 10-K · filed 2022-03-17 |
| 2021-09-30 | $273.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |